Performance

ACRS +82.76%

Watchlist

Select an item

RETURNS	1D	YTD	1Y	5Y Ann.	Max DD	Sharpe	Div. Yield
ACRS	+8.72%	+40.86%	+82.76%	-23.70%	-49.81%	1.00	0.00%

Summary

ACRS at a glance

ACRS returned +82.76% over the past year and -23.70% a year over five years. Its worst drop in that year was -49.81%, smaller than 23% of stocks on Redstone, and its Sharpe ratio of 1.00 beats 75% of stocks on Redstone. It pays no dividends.

Ranking

How ACRS ranks

Current Drawdown

-35.12%

Rolling Volatility

69.08%

Actions

Metrics

Risk Indicators

Alpha92.45%

Beta0.60x

Sharpe1.00

Sortino2.00

Omega1.24

Calmar1.66

Martin5.05

Profile

About ACRS

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company. It focuses on developing novel drug candidates for immuno-inflammatory diseases using its proprietary KINect drug discovery platform.

Sector: Health Care
Industry: Pharmaceutical Preparations
Market cap: $657M
Listed: Oct 2015
Employees: 73
Headquarters: Wayne, PA
Website: aclaristx.com

Comparisons

ACRS: Aclaris Therapeutics, Inc.

ACRS at a glance

How ACRS ranks

Current Drawdown

Rolling Volatility

About ACRS

Related comparisons